2026 NPPES data Corneal and Contact Management Optometrist NPI 1184668121 O.D.
Verify on CMS →

KEVIN ROSIN, O.D.

Corneal and Contact Management Optometrist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
450
Medicare Part D claims · 152 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
11%
generic claims · 89% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.5122/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$7.9K
98 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KEVIN ROSIN, O.D. reported a CMS MIPS final score of 99.5122/100 — above the 83.1 national average — and filed 450 Medicare Part D claims in 2023.

99.5122/100
MIPS score · +16 vs avg
450
Part D claims, 2023
11%
generic prescribing
$7.9K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KEVIN ROSIN, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about KEVIN ROSIN, O.D.?

High performer (top quartile)

NPI registry status

Active

Issued 06/16/2006

NPI 1184668121

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

450 91% vs specialty avg

2023 prescription claims

Specialty avg: 235

MIPS final score

99.5122/100 16.412200000000013% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Corneal and Contact Management Optometrist compares to other specialties among New York providers

New York providers

Corneal and Contact Management Optometrist share within New York

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within New York

Medicare quality performance — MIPS

KEVIN ROSIN, O.D.'s 2023 MIPS final score plotted against the Corneal and Contact Management Optometrist national average

High performer (top quartile)
MIPS Final Score
99.5122/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Corneal and Contact Management Optometrist) — 99.5122/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Corneal and Contact Management Optometrist) — 99.5122/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KEVIN ROSIN, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 30 E 60TH ST, NEW YORK, NY, 10022, with a listed phone of (212) 355-5145. NPI 1184668121 was issued on 06/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROSIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 450 prescription claims written by this provider, covering 152 Medicare beneficiaries and totaling roughly $292K in drug spend, split 89% brand-name and 11% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.5122/100 for the 2023 performance year (Quality 100, Cost 85.91), compared with the national average of 83.1.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

30 E 60TH ST
NEW YORK, NY 10022

Provider Details

NPI 1184668121
Specialty Corneal and Contact Management Optometrist
Credentials O.D.
Gender Male
NPI Issued 06/16/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.5122
Final Score
Avg: 83.1
100
Quality
85.91
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where KEVIN ROSIN, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ARTHUR M. COTLIAR, MD PLLC
NEW YORK, NY
DRS FARKAS, KASSALOW, RESNICK AND ASSOCIATES PC
NEW YORK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KEVIN ROSIN, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$7.9K

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to KEVIN ROSIN, O.D.. To verify KEVIN ROSIN, O.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

KEVIN ROSIN, O.D. — brand share 89.0%
Specialty average (est.)

89% brand-name claims vs 11% generic, on 450 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

450
Total Claims
$292K
Total Drug Cost
152
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
602
Total Day Supply
16,740
Brand vs Generic
89% brand / 11% generic
Brand Drug Cost
$290K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
0.83
Gender Split
80% female / 20% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KEVIN ROSIN, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Restasis
Cyclosporine
99
Xiidra
Lifitegrast
58
Cequa
Cyclosporine
34
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
26
Tobradex St
Tobramycin/Dexamethasone
25
Prolensa
Bromfenac Sodium
24
Tyrvaya
Varenicline Tartrate
23
Restasis Multidose
Cyclosporine
20
Lotemax Sm
Loteprednol Etabonate
15
Zylet
Tobramycin/Lotepred Etab
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How KEVIN ROSIN, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

KEVIN ROSIN, O.D.'s 450 claims are above the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as ROSIN.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is KEVIN ROSIN, O.D.'s specialty?
KEVIN ROSIN, O.D. specializes in Corneal and Contact Management Optometrist and practices in NEW YORK, New York. Credentials: O.D..
How much does KEVIN ROSIN, O.D. prescribe under Medicare Part D?
In 2023, KEVIN ROSIN, O.D. wrote 450 Medicare Part D claims totaling $292K in drug costs for 152 beneficiaries.
What is KEVIN ROSIN, O.D.'s Medicare quality score?
KEVIN ROSIN, O.D. has a CMS MIPS Final Score of 99.5122/100 (Quality: 100, Cost: 85.91). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KEVIN ROSIN, O.D. located?
KEVIN ROSIN, O.D. is located at 30 E 60TH ST, NEW YORK, NY, 10022. Phone: (212) 355-5145.
What is KEVIN ROSIN, O.D.'s NPI number?
KEVIN ROSIN, O.D.'s National Provider Identifier (NPI) is 1184668121, issued on 06/16/2006.
Does KEVIN ROSIN, O.D. prescribe more brand-name or generic drugs?
KEVIN ROSIN, O.D.'s prescribing is 89% brand-name and 11% generic drugs by claim count, with $290K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does KEVIN ROSIN, O.D. prescribe most often?
Based on 2023 Medicare Part D data, KEVIN ROSIN, O.D.'s most frequently prescribed drugs include Restasis, Xiidra, Cequa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KEVIN ROSIN, O.D. accept Medicare?
KEVIN ROSIN, O.D. appears in CMS Medicare data with 450 Part D claims and 152 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KEVIN ROSIN, O.D.'s credentials?
KEVIN ROSIN, O.D.'s NPI is 1184668121 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology